Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.50 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.47 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.45 |
| ▸ | SLC22A12 | Q96S37 | 5/20 | 0.45 |
| ▸ | XDH | P47989 | 1/20 | 0.43 |
| ▸ | PIM1 | P11309 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16917824 | 0.87 | IMPDH2 (0.57) | CA1CA2ARIMPDH2IMPDH1 | |
| SCHEMBL28203557 | 0.86 | CA1 (0.60) | CA1CA2MCL1ALOX15XDH | |
| SCHEMBL20561064 | 0.84 | MCL1 (0.58) | CA1CA2MCL1ALOX15XDH | |
| SCHEMBL31236642 | 0.84 | MCL1 (0.58) | CA1CA2MCL1ALOX15XDH | |
| SCHEMBL13192347 | 0.84 | CA1 (0.42) | CA1CA2MCL1ARIMPDH2 | |
| SCHEMBL769553 | 0.81 | CA1 (0.55) | CA1CA2MCL1ALOX15XDH | |
| SCHEMBL29039496 | 0.81 | CA1 (0.50) | CA1CA2MCL1ALOX15SLC22A12 | |
| SCHEMBL59702 | 0.81 | CA1 (0.69) | CA1CA2MCL1IMPDH2IMPDH1 | |
| SCHEMBL11228244 | 0.80 | IMPDH2 (0.59) | CA1CA2ARIMPDH2IMPDH1 | |
| SCHEMBL23191270 | 0.80 | ALDH1A1 (0.46) | CA1CA2MCL1ARIMPDH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8008507-B2 | Fluorescent diketopyrrolopyrroles | BASF SE Ludwigshafen (DE) | 2011-08-30 | — | — | US | disclosed |
| EP-1817392-B1 | FLUORESCENT DIKETOPYRROLOPYRROLES | CIBA HOLDING INC (CH) | 2009-01-07 | — | — | EP | disclosed |
| US-20080217581-A1 | Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance | CIBA CORPORATION | 2008-09-11 | — | — | US | disclosed |
| EP-1817392-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006061343-A1 | FLUORESCENT DIKETOPYRROLOPYRROLES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080217581-A1 | Inks, colorants, pigmented plastics for coatings, non-impact-printing material, color filters, cosmetics, polymeric ink particles, toners, fluorescent tracers; high in the efficiency of electrical energy utilisation and high in luminance | TYR, MC1R, IK | CA1 4734/4885CA2 2784/4885MCL1 4415/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.